Rep. Barton oversight subcommittee to review OTC tests for illicit drugs at Sept. 26 hearing.
This article was originally published in The Tan Sheet
Executive Summary
REP. BARTON OVERSIGHT SUBCOMMITTEE TO REVIEW OTC TESTS FOR ILLICIT DRUGS at a hearing slated for Sept. 26. The hearing before Rep. Joe Barton's (R-Tex.) House Commerce/Oversight Subcommittee is expected to focus on parents' access to drugs-of-abuse testing technology, and likely will address FDA's moves to regulate an over-the-counter drug testing service in 1995.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning